This article provides insufficient context for those unfamiliar with the subject. Please help improve the article by providing more context for the reader. (March 2021) (Learn how and when to remove this template message)
Drofenine
Identifiers
  • 2-(diethylamino)ethyl 2-cyclohexyl-2-phenylacetate
CAS Number
PubChem CID
ChemSpider
UNII
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.114.553 Edit this at Wikidata
Chemical and physical data
FormulaC20H25NO3
Molar mass327.424 g·mol−1
3D model (JSmol)
  • CCN(CC)CCOC(=O)C(C1CCCCC1)C2=CC=CC=C2
  • InChI=1S/C20H31NO2/c1-3-21(4-2)15-16-23-20(22)19(17-11-7-5-8-12-17)18-13-9-6-10-14-18/h5,7-8,11-12,18-19H,3-4,6,9-10,13-16H2,1-2H3
  • Key:AGJBLWCLQCKRJP-UHFFFAOYSA-N

Drofenine is an antimuscarinic antispasmodic drug used for relaxing smooth muscle, thereby treating conditions, such as: dysmenorrhea, and pain in the gastrointestinal tract, biliary passages, and urogenital tract. Drofenine is assumed to work by increasing the levels of the protein TRPV3.[1][2][3]

References

  1. ^ Kunysz EL, Michel AD, Whiting RL (March 1988). "Functional and direct binding studies using subtype selective muscarinic receptor antagonists". British Journal of Pharmacology. 93 (3): 491–500. doi:10.1111/j.1476-5381.1988.tb10303.x. PMC 1853838. PMID 2897216.
  2. ^ Bodur E, Cokuğraş AN, Tezcan EF (February 2001). "Inhibition effects of benactyzine and drofenine on human serum butyrylcholinesterase". Archives of Biochemistry and Biophysics. 386 (1): 25–9. doi:10.1006/abbi.2000.2188. PMID 11360997.
  3. ^ Deering-Rice CE, Mitchell VK, Romero EG, Abdel Aziz MH, Ryskamp DA, Križaj D, et al. (October 2014). "Drofenine: A 2-APB Analogue with Greater Selectivity for Human TRPV3". Pharmacology Research & Perspectives. 2 (5): e00062. doi:10.1002/prp2.62. PMC 4115637. PMID 25089200.